Through The Fly's Eyes: IPO & Syndicate Preview
from Joseph Lazzaro of Theflyonthewall.com
Wall Street's equity market kicks into fifth gear this week with 8 IPOs and 6 Secondaries on the docket.
Those deals tentatively scheduled to price include:
SP Acqusition (DSP), a 36M-share IPO for this business financing company. UBS Investment and Ladenburg Thalmann are the lead managers. Filing pricing: $10.00.
Mediatech Investment (MDTC), a 10M-share IPO for this business financing company. UBS Investemnt and JMP Securities are the lead managers. Filing range: $14.00-$16.00.
EyeTel Imaging (EYT), 4.025M-share IPO for this blindness systems company. Maxim is the lead managers. Filing range: $7.00-$8.00.
Affinion Group (AFI), a 32.5M-share IPO for this marketing services company. Morgan Stanley and Deutsche Bank are the lead managers. Filing range: $15.00-$17.00.
Compellent Technologies (CML), a 6.9M-share IPO for this network storage company. Morgan Stanley is the lead manager. Filing range: $10.00-$12.00.
Targanta Theratpeutics (TARG), a 5.75M-share IPO for this pharmaceutical company. Credit Suisse is the lead manager. Filing range: $12.00-14.00.
Textainer Group (TGH), a 9M-share IPO for this freight equipment leasing company. Credit Suisse and Wachovia are the lead managers. Filing range: $19.00-$21.00.
Virgin Mobile USA (VM), a 27.5M-share IPO for this wireless telecom company. Lehman Brothers, Merrill Lynch, Bank of America and Bear Stearns are the lead managers. Filing range: $15.00-$17.00.
TomoTherapy (TTPY), a 9.78M-share Secondary for this medical devices company. Merrill Lynch and Piper are the lead managers.
Layne Christensen (LAYN), a $173 million Secondary for this drilling services company. UBS Investment and Merrill Lynch are the lead managers.
Neurobiologiacl Technologies (NTIID), an 18.9M-share Secondary for this neurological medicines company. Merriman is the lead manager.
Bionovo (BNVI), a 11.4M-share Secondary for this pharmaceutical company. BMO Capital Markets and Canaccord Adams are the lead managers.
JA Solar (JASO), a 6.3M-share Secondary for this solar cell systems company. Credit Suisse and Lehman Brothers are the lead managers.
Obagi Medical Products (OMPI), a 7.25M-share Secondary for this pharmaceutical company. Thomas Weisel, Robert W. Baird and CIBC World Markets are the lead managers.
For the latest market intelligence on IPOs, Syndicate, and after-market trades, check out The FLY Syndicate at www.theflyonthewall.com. [Subscription required.]